Protagenic Therapeutics (PTIX) had the highest return in January 2016 by a US stock in the Biotechnology Industry and the Nasdaq Composite (IXIC), returning 429.4%.

ASSET	MONTH	% RETURN
Protagenic Therapeutics (PTIX)	January 2016	429.41%
Sunshine Biopharma (SBFM)	January 2016	53.08%
Fennec Pharmaceuticals (FENC)	January 2016	42.07%
PharmaCyte Biotech (PMCB)	January 2016	31.11%
ProMIS Neurosciences (PMN)	January 2016	25%
CervoMed (CRVO)	January 2016	24%
Biocardia (BCDA)	January 2016	14.29%
CASI Pharmaceuticals (CASI)	January 2016	13.68%
MediciNova (MNOV)	January 2016	11.94%
Uniqure (QURE)	January 2016	11.57%
Anixa Biosciences (ANIX)	January 2016	9.29%
iBio, Inc Common Stock (IBIO)	January 2016	9.09%
vTv Therapeutics (VTVT)	January 2016	6.46%
Renovaro Biosciences (RENB)	January 2016	6.25%
Avita Medical (RCEL)	January 2016	6.08%
Ascendis Pharma A-S (ASND)	January 2016	5.43%
Larimar Therapeutics (LRMR)	January 2016	5.39%
Lifecore Biomedical (LFCR)	January 2016	3.8%
InMed Pharmaceuticals (INM)	January 2016	3.75%
Inovio Pharmaceuticals (INO)	January 2016	2.61%
Kazia Therapeutics Ltd ADR (KZIA)	January 2016	2.42%
Dynavax Technologies (DVAX)	January 2016	2.29%
Oncolytics Biotech (ONCY)	January 2016	1.83%
Skye Bioscience, Inc Common Stock (SKYE)	January 2016	1.5%
MDxHealth SA ADR (MDXH)	January 2016	1.19%